Cardinal Health

sponsored content

A Deep-dive Into Specialty Pharma

A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.

Pharma

Cardinal Health, Eli Lilly collaborate on Alzheimer’s imaging agent

Cardinal Health (NYSE:CAH) will manufacture and distribute a radioactive imaging agent from Eli Lilly (NYSE:LLY) that could help doctors diagnose Alzheimer’s disease. The imaging agent, called Amyvid, is scheduled for commercial launch on June 1, according to a statement from Dublin, Ohio-based Cardinal. Amyvid was approved by the U.S. Food and Drug Administration in April. […]

Pharma

New decision-support tool to help doctors follow cancer, arthritis best practices

New decision support technology from Cardinal Health (NYSE:CAH) is designed to help physicians follow cancer and rheumatoid arthritis “clinical pathways” — evidence-based treatment regimens. The new technology, called PathWare Solutions, would be purchased by a health insurance plan or payer, which would then make it available to physicians in its network, according to a spokeswoman […]

Devices & Diagnostics

Cardinal Health to buy drug distributor Dik Drug

Consolidation in the U.S. drug distribution business continues as Cardinal Health (NYSE:CAH) has purchased a Chicago-area regional drug wholesaler, Dik Drug Company. The acquisition was first reported by Adam Fein at Drug Channels and confirmed to MedCity News in a statement from a Cardinal spokeswoman. Dublin, Ohio-based Cardinal said it signed a definitive agreement to […]